Resources

Publications

10/10/2024
- Oncology
Long-Term Breast Cancer Response to CDK4/6 Inhibition Defined by TP53-Mediated Geroconversion
Cancer Cell
10/01/2024
- Oncology
Geospatial and Molecular Characterization of Tumor Immune Cell Infiltration in NSCLC
IASLC WCLC 2024
09/30/2024
- Oncology
Calibrating Observational Health Record Data Against a Randomized Trial
JAMA Network Open
09/26/2024

Circulating Tumor DNA Predicts Venous Thromboembolism in Patients With Cancers
Journal of Thrombosis and Haemostasis
09/15/2024
- Oncology
Uncovering Molecular Differences in Pancreatic Ductal Adenocarcinoma Tissues From Black and White Patients in the US
AACR PANC 2024
09/09/2024
- Oncology
Comprehensive genomic profiling provides patients access to novel matched therapies in a diverse real-world cohort of advanced lung cancer patients
ESMO 2024
09/09/2024
- Oncology
The association of changes in circulating tumor fraction and in actionable variant allele frequencies with clinical outcomes in real world diverse cohort of advanced patients treated with tyrosine kinase inhibitors
ESMO 2024
09/09/2024
- Oncology
Impact of RAS and BRAFV600E mutations on tumor immune microenvironment and associated genomic alterations in patients with microsatellite instability (MSI) or DNA mismatch repair deficient (dMMR) colorectal cancers
ESMO 2024
09/09/2024
- Oncology
Impact of AI clinical trial program on screening, matching, and enrollment of patients over 6 months
ESMO 2024
09/05/2024
- Oncology
LIBERTY: LIquid Biopsy for rElapsed/RefracTorY Neuroblastoma – a Pilot Study of Characterization of Circulating Tumor DNA Alterations in Patients With Relapsed and Refractory Neuroblastoma Using a Clinically Validated Liquid Biopsy Platform
AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research 2024

16 17 18